2 Hot Stocks to Watch: Novavax, Inc. (NASDAQ:NVAX), Schlumberger Limited (NYSE:SLB)

Novavax, Inc. (NASDAQ:NVAX)

The shares of Novavax, Inc. (NASDAQ:NVAX) started off the last trading session with the price of $2.08 while closing the day with the price of $2.02. The shares of Novavax, Inc. (NASDAQ:NVAX) Fell -4.72% with the Loss of -0.06 points.

The shares of Novavax, Inc. (NASDAQ:NVAX) traded with the day volume of 5.64 Million shares whereas its average trading volume is 11.65 Million.

While analyzing the past performance of the stock we can see that the shares of Novavax, Inc. (NASDAQ:NVAX) Loss -1.94% in the last week while Falling -14.77% in the last month. Past quarter performance shows the green light with 85.32%. The semi-annual and annual performance shows 75.65% and 62.9% respectively.

Some critical values of the shares of Novavax, Inc. (NASDAQ:NVAX) to be discussed here are: the beta which shows the value at 2.4 while Average True Range of Novavax, Inc. (NASDAQ:NVAX) demonstrate the value at 0.16. The weekly and monthly volatility of the shares of Novavax, Inc. (NASDAQ:NVAX) are indicated at 5.28% and 7.72%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 42.01.

While studying the financial position of the shares of Novavax, Inc. (NASDAQ:NVAX), we can see that the Market capitalization of the company is at 604.12 Million. The shares outstanding for the company is 299.07 Million and the shares float stands at 279.25 Million. The income of the company stand at -183800000 while the sales stand at 31.2 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -0.63, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 19.36, the Return on Asset ROA stood at -0.543 and the Return on Equity ROE depicted at 2.784 while Return on Investment ROI is at 0.


Schlumberger Limited (NYSE:SLB)

Schlumberger Limited (NYSE:SLB) started its previous trading session at $66.75 and closed at $65.52 showing a Fell of -3.28 Percent.

The Company traded with an average Volume of 8.69 Million whereas, its Day Volume stood at 7.35 Million.

Looking at the performance of the stock, Schlumberger Limited (NYSE:SLB) Gain 0.26% in the last week in its shares price and 1.74% in the last month. Quarterly performance shows a green of 1.75 Percent while Semi-Annual and Annual performances shows a -3.11 and -16.41 percent respectively.

Beta for Schlumberger Limited (NYSE:SLB) stands at 1.1 while the ATR (average true range) is at 1.73. The Stock’s Weekly and Monthly Volatility is 2.62% and 2.42% respectively showing a RSI value of 41.66.

While studying the financial position of the shares of Schlumberger Limited (NYSE:SLB), we can see that the Market capitalization of the company is at 90.94 Billion. The shares outstanding for the company is 1.39 Billion and the shares float stands at 1.38 Billion.

The Company generated an income of -1580000000 and the sales of 30.44 Billion in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-1.14 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 2.99 respectively.

The Return on Assets stands at -0.02, ROE shows a value of -0.038 and ROI for Schlumberger Limited (NYSE:SLB) is -0.022 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment